基本信息
产品编号: |
C10831 |
||||
产品名称: |
9-cis-Retinoic acid |
||||
CAS: |
5300-03-8 |
储存条件 |
粉末 |
-20℃充氮保存 |
四年 |
|
|
||||
分子式: |
溶于液体 |
-80℃ |
六个月 |
||
分子量 |
300.44 |
-20℃ |
一个月 |
||
化学名: |
(2E,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid |
||||
Solubility (25°C): |
|||||
体外:
|
DMSO |
25mg/mL (83.21mM; Need ultrasonic) |
|||
Ethanol |
|
||||
Water |
|
||||
体内(现配现用): |
1.请依序添加每种溶剂:10% DMSO→40% PEG300→5% Tween-80→45% saline Solubility: 2.5mg/mL (8.32mM); Suspended solution; Need ultrasonic |
||||
此⽅案可获得 2.5mg/mL (8.32mM) 的均匀悬浊液,悬浊液可⽤于⼝服和腹腔注射。 以 1mL ⼯作液为例,取 100μL 25.0mg/mL 的澄清 DMSO 储备液加到 400μL PEG300 中,混合均匀;向上述体系中加⼊ 50μL Tween-80,混合均匀;然后继续加⼊ 450μL ⽣理盐⽔定容⾄ 1mL。 |
|||||
2.请依序添加每种溶剂:10% DMSO→90% (20% SBE-β-CD in saline) Solubility: 2.5mg/mL (8.32mM); Suspended solution; Need ultrasonic |
|||||
此⽅案可获得 2.5mg/mL (8.32mM) 的均匀悬浊液,悬浊液可⽤于⼝服和腹腔注射。 以 1mL ⼯作液为例,取 100μL 25.0mg/mL 的澄清 DMSO 储备液加到 900μL 20% 的 SBE-β-CD ⽣理盐⽔⽔溶液中,混合均匀。 |
|||||
<1mg/ml表示微溶或不溶。 |
|||||
普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 |
|||||
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |
制备储备液
浓度
溶液体积 质量 |
1mg |
5mg |
10mg |
1mM |
3.3285mL |
16.6423mL |
33.2845mL |
5mM |
0.6657mL |
3.3285mL |
6.6569mL |
10mM |
0.3328mL |
1.6642mL |
3.3285mL |
生物活性
产品描述 |
一种有效的 RAR/RXR 激动剂。9-cis-Retinoic acid 可诱导细胞凋亡 (apoptosis),调节细胞周期并具有抗癌,抗炎和神经保护活性。 |
|
体外研究 |
9-cis-Retinoic acid (1-10μM; 0-5 days; CA 9-22 and NA cells) treatment significantly decreases proliferation in a dosedependent manner in CA 9-22 and NA cells. 9-cis-Retinoic acid (1μM; 24 hours) treatment significantly increases PPARγ functional activity by >200% in CA 9-22 and NA aerodigestive cells. 9-cis-Retinoic acid treatment results in the formation of a nuclear PPARγ-RXRα heterodimer supershift complex in CA 9-22 cells. 9-cis-Retinoic acid inhibits proliferation and induces apoptosis in cutaneous T-cell lymphoma (CTCL) in a dose-dependent and time-dependent manner. 9-cis-Retinoic acid also induces G0/G1 cell cycle arrest by downregulation of cyclin D1. 9-cisRetinoic acid significantly decreases phosphorylation of JAK1, STAT3, and STAT5 and downregulated Bcl-xL and cyclin D1 Cell Proliferation Assay |
|
Cell Line: |
CA 9-22 and NA cells |
|
Concentration: |
1μM, 10μM |
|
Incubation Time: |
0 day, 1 day, 3 days, 5 days |
|
Result: |
Significantly decreased proliferation. |
|
体内研究 |
9-cis-Retinoic acid (1mg/kg; intravenous injection; daily; for 10 days; male C57BL/6J mice) treatment significantly decreases the serum ALT and AST level, alleviates hepatic necrosis of the bile duct ligation (BDL)-mice |
|
Animal Model: |
Male C57BL/6J mice (6-8 weeks; 19-22 g) treatment with bile duct ligated |
|
Dosage: |
1mg/kg |
|
Administration: |
Intravenous injection; daily; for 10 days |
|
Result: |
Significantly decreased the serum ALT and AST level, alleviated hepatic necrosis. |
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)
摩尔浓度计算公式
用本工具协助配置特定浓度的溶液,使用的计算公式为:
开始浓度 x 开始体积 = 最终浓度 x 最终体积
稀释公式
稀释公式一般简略地表示为:C1V1 = C2V2 ( 输入 输出 )